Breast Cancer

U.S. FDA Approves Cancer Drug

Published in Cancer Weekly, May 18th, 1998

The U.S. Food and Drug Administration (FDA) approved a drug for breast cancer aimed at women whose illness is not being helped by other drugs.

The FDA said it gave drugmaker Hoffmann-La Roche accelerated approval for Xeloda, an oral drug designed for patients whose breast cancer is not responding to other drugs.

"Xeloda is a significant advance in the treatment of metastatic (spreading) breast cancer. At last, patients can take an effective pill, in their homes, to treat their cancer," said Dr. Linda Vahdat, Columbia-Presbyterian Medical Center, New York, New York, said in a statement released by Roche.

Xeloda, known generically...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-05-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry